NFATC1 and diabetes mellitus: Our findings demonstrate that hyperglycemia in cultured myocytes and in vivo in cardiac tissues from animal models of diabetes noticeably promoted resistin expression by inducing NFATc activation which was mitigated by the NFATc inhibitor, VIVIT.